Association between late-life neuropsychiatric symptoms and cognitive decline in relation to white matter hyperintensities and amyloid burden

Manuscript Number: 

21-5267R2

Author(s): 
Marilyn Albert, Carol K. Chan, Corinne Pettigrew, Paul B. Rosenberg, Anja Soldan, Mei-Cheng Wang, Yuxin Zhu

Disclosures

Marilyn Albert

  • Nothing to Disclose

Carol K. Chan

  • Equity:
    publicly traded firms

Corinne Pettigrew

  • Nothing to Disclose

Paul B. Rosenberg

  • Consulting Fees:
    All < 5K annually GLG, Leerink, Cerevel, Cerevance, Bioxcel, Sunovion, Acadia, Food and Drug Administration, Medalink, Novo Nordisk, Noble Insights, TwoLabs
    Grants
    • Agency: 
      Lilly
      Dates: 
      2010-present
    • Agency: 
      Functional Neuromodulation Inc.
      Dates: 
      2012-present

Anja Soldan

  • Nothing to Disclose

Mei-Cheng Wang

  • Nothing to Disclose

Yuxin Zhu

  • Nothing to Disclose